Role of Diagnostics: NT-proBNP in management of Heart Failure

Wednesday, 16th Nov 2022

6:30 – 7:30 pm AEDT (GMT +11) | 3:30pm – 4:30pm (GMT+8)

View other time zones

This webinar will discuss the latest updates on the management of Heart failure. With new CVD risk assessment tools available, our experts will discuss how they might best be applied in clinical practice.

We look forward to you joining us at the live webinar!

Faculty

Chair & Speaker

Prof. Andrew Sindone

Director Heart Failure Unit,
Concord Hospital
Head of department of Cardiology,
Ryde Hospital

Read More

Professor Andrew Sindone B. Med (hons), MD, FRACP, FCSANZ, FNHFA is Director of the Heart Failure Unit and Department of Cardiac Rehabilitation at Concord Hospital and Head of Department of Cardiology at Ryde Hospital. He has received multiple awards, has been Principal Investigator in over 40 multicentre clinical trials and has presented over 85 research papers. He is a Co-chairman of the NSW Cardiovascular Expert Reference Group, Fellow of the Heart Foundation of Australia was on the Scientific Committee for the World Congress of Cardiology in 2002 and is co-author of the Australian Guidelines for the Management of Heart Failure.

Speaker

Prof. Jonathan Shaw

Deputy Director at Melbourne’s Baker Heart and Diabetes Institute

Read More

Professor Jonathan Shaw is Deputy Director at Melbourne’s Baker Heart and Diabetes Institute, where his research focuses on epidemiology and clinical research in diabetes, and he is also a consultant physician in the diabetes services. In 2014, he was included in the Thomson Reuters The World’s Most Influential Scientific Minds, which listed the 1% most highly cited scientists in the world. In 2017 and 2018, he was included in the Clarivate list of the world’s most Highly Cited Researchers. In 2020, he was listed in the Stanford University listing of the world’s top 2% of researchers.

Speaker

Assoc Prof. Christine Burdeniuk

Associate Professor
Flinders University, SALHN ( South Adelaide Local Health Network)

Read More

Assoc Prof Burdeniuk studied medicine at Flinders University after completion of a Bachelor of Science with Honours at the University of Adelaide. She completed her advanced training in Cardiology and Echocardiography in 2007 at Flinders Medical Centre before pursuing a further Clinical Fellowship in Heart Failure and Transplantation at the Alfred Hospital in Melbourne. Since 2009 Dr Burdeniuk has been providing care to patients with advanced heart failure and pulmonary arterial hypertension throughout SALHN and established a tertiary level heart failure service in Mt Gambier. She is actively involved in heart failure clinical trials and Australian heart failure guidelines.

Who should attend:

Cardiologist, Endocrinologist, Pathologist, Cardiology advanced Trainees, GP’s, Geriatricians, Basic Physician trainees

Key reasons to attend:

• To learn about the Latest advances and management of Heart failure.
• To understand the value of NT-proBNP in clinical use.
• To know the clinical approach of managing patients with Acute and Chronic Heart Failure.
• To be aware on the guidelines on usage of NT-proBNP.
• To hear from APAC Endocrinologist on real world clinical implementation of NT-proBNP in T2DM patients

Agenda